4Tuder RM,Cool CD,Geraci MW,et al.Prostacyclin synthase expression is decreased inhngs from patients with severe pulmonary hypertension.Am J Respir Crit Care Med,1999,159:1925-1932.
5Giaid A,Yanagisawa M,Langleben D,et al.Expression of endobethelin-1 in the lungs of patients with pulmonary hypertension.N EnglJ Med,1993,328:1732-1739.
6Clapp LH,Finney P,Turcato S,et al.Differentialeffects of stable prostacyclin analogues on smooth muscle proliferation andcyclic AMP generation in human pulmonary artery.Am J RespirCell Mol Biul,2002,26:194-201.
8Schermuly RT,Inhulte C,Ghofrani HA,et al.Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension:amplification by different type phosphodiesterase inhibitors.Respir Res,2005,6:76.
9Schermuly RT,Pullamsetti SS,Kwapiszewska G,et al.Phosphodiesterase 1 upregulation in pulmonary arterial hypertension:target for reverse-remodeling therapy.Circulation,2007,115:2331-2339.
10Wharton J,Strange JW,Moller GM,et al.Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.Am J Respir Crit Care Med,2005,172:105-113.
